Scientists observe drug target that can reduce pain when activated
A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.
Conditions that cause chronic pain can be difficult to manage. These include sciatica, cancer and rheumatoid arthritis. Chronic pain mechanisms are complicated, which is one of the reasons why pain management is so difficult, explains Professor Norimitsu Morioka of the Department of Pharmacology, Graduate School of Biomedical & Health Sciences, Hiroshima University. This difficulty decreases the quality of life of patients that, in many cases, can suffer from constant pain with little to no relief. General-purpose pain-relieving medication is often ineffective. Even morphine, possibly the best painkiller according to Assistant Professor Yoki Nakamura, also of the Department of Pharmacology, can fail to inhibit pain in cancer patients.
“Chronic pain is increasing worldwide […] associated with increasing population,” warns Morioka. The increasing number of sufferers of chronic pain means the establishment of new therapeutics is urgent, hence why the results of these types of studies can have important consequences on healthcare for these patients.
Previous research had shown that activating a type of cell receptor (REV-ERBs) that sends chemical signals inside the cell to block the production of certain genes regulates pain-causing and inflammatory molecules inside the body. Such research had shown that a molecule used to ‘turn on’ the REV-ERBs had decreased the production of inflammatory molecules in immune cells but
“Nobody checked the effect of REV-ERBs agonist [stimulator] on nociceptive behaviors [pain reactions] or chronic pain so first we checked the effect of REV-ERBs agonist on chronic pain,” explains Nakamura.
Until now, research has also only looked into one type of pain model at a time. Morioka elaborates that
“I think it is not enough to reduce by one target […] I think it is important to cover a lot of molecules mediating chronic pain,” and REV-ERBs seems to be a fitting target “So it is very exciting.”
The research group applied this knowledge to determine if activating the nuclear receptor REV-ERBs in specialized spinal cord cells (astrocytes) results in pain relief in mice. The team treated mice with differing levels of pain sensitivity with molecules that turned on REV-ERBs. The molecules studied can be easily found in today’s pain-relieving drugs according to the team. To test whether there was a notable effect on pain; mice were touched with a filament on their hind paw. Pain was recorded when mice raised their paw away from the filament. Light touches made mice with chronic pain react whereas ‘normal’ mice only moved when the force was increased. Mice with chronic pain when treated with a REV-ERBs stimulator did not react to the lighter touches (depending on the type of chronic pain they had). Through these observations, the research group concluded they did not feel as much pain as the untreated mice with the same type of chronic pain.
Based on these results, the researchers believe that this new target for pain relief could benefit many types of chronic pain sufferers. They plan to perform further research and drug screening experiments to develop new drugs for various types of chronic pain relief.
The Latest on: Chronic pain relief
via Google News
The Latest on: Chronic pain relief
- Opioids only modestly improve pain relief, function in OA, not QoLon November 18, 2019 at 1:37 pm
“One of the main culprits [driving opioid use] are chronic pain patients and one of the most highly prescribed conditions ... a meta-regression demonstrated that opioid dosage had no impact on pain ...
- Stem Cell Treatment Relieves Chronic Painon November 18, 2019 at 10:23 am
Learn more about a revolutionary treatment giving relief to chronic pain sufferers. How stem cells are changing the game when it comes to treating pain. WEBSITE: Buckeye Physical Medicine and Rehab ...
- Learn how to spot the biggest source of chronic pain in dogson November 18, 2019 at 5:45 am
Osteoarthritis (OA) is the most common cause of chronic pain in dogs, but early intervention and comprehensive treatment can help dog owners and veterinarians successfully manage pain so dogs can stay ...
- Chronic Pain Treatment Market by Product, by...on November 17, 2019 at 11:29 pm
New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Pain Treatment Market by Product, by Indication, by Application, by Distribution Channel, by ...
- Chronic Pain Treatment Market to Garner Overwhelming Hike In Revenues by 2026on November 17, 2019 at 7:24 pm
Nov 17, 2019 (Market Prediction via COMTEX) -- This report focuses on Chronic Pain Treatment volume and value at global level, regional level and company level. From a global perspective, this report ...
- The analgesic effect of refeeding on acute and chronic inflammatory painon November 14, 2019 at 3:11 am
In CFA-induced chronic inflammatory pain model (twice CFA injection), refeeding reduced both spontaneous pain ... The time mice spent licking was measured during each 5 minutes by an observer who was ...
- What Are Some Alternatives To Opioids For Chronic Pain?on November 13, 2019 at 11:58 am
What are the alternatives to opioids when the patient suffers from chronic pain? originally appeared on Quora ... Stem cell therapy is also at the forefront of the pain treatment. Stem cells are ...
- Why Is There Such A Prejudice Against People Who Need Opioids For Chronic Pain?on November 13, 2019 at 11:51 am
Physicians who treat chronic pain patients also feel at risk due to new regulations and increased scrutiny over their prescribing and treatment processes. Some feel safer cutting opioid prescriptions ...
- Injectable electrodes may help treat everything from chronic pain to depressionon November 13, 2019 at 11:29 am
A novel drug-free treatment for health conditions ranging from chronic pain to epileptic seizures or depression could be on the horizon — and it involves injectable electrodes. The concept builds on ...
- Opioid backlash leaves some to struggle with chronic pain as physicians write fewer prescriptionson November 13, 2019 at 9:03 am
When her prescription ran out in the stipulated 30 days for refills, she had nowhere to turn to for relief. Her doctor appeared reluctant to renew the medication ... up because it’s just more hassle ...
via Bing News